299 related articles for article (PubMed ID: 33709684)
1. Dual-Sensitive PEG-Sheddable Nanodrug Hierarchically Incorporating PD-L1 Antibody and Zinc Phthalocyanine for Improved Immuno-Photodynamic Therapy.
Su Z; Xiao Z; Huang J; Wang Y; An Y; Xiao H; Peng Y; Pang P; Han S; Zhu K; Shuai X
ACS Appl Mater Interfaces; 2021 Mar; 13(11):12845-12856. PubMed ID: 33709684
[TBL] [Abstract][Full Text] [Related]
2. Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy.
Gao D; Lo PC
J Control Release; 2018 Jul; 282():46-61. PubMed ID: 29673646
[TBL] [Abstract][Full Text] [Related]
3. Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy.
Huang J; Xiao Z; An Y; Han S; Wu W; Wang Y; Guo Y; Shuai X
Biomaterials; 2021 Feb; 269():120636. PubMed ID: 33453632
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2 inhibitor uploaded upconversion nanophotosensitizers to overcome the photodynamic therapy resistance of cancer through adjuvant intervention strategy.
Liu X; Fan Z; Zhang L; Jin Z; Yan D; Zhang Y; Li X; Tu L; Xue B; Chang Y; Zhang H; Kong X
Biomaterials; 2017 Nov; 144():73-83. PubMed ID: 28823845
[TBL] [Abstract][Full Text] [Related]
5. Novel Core-Interlayer-Shell DOX/ZnPc Co-loaded MSNs@ pH-Sensitive CaP@PEGylated Liposome for Enhanced Synergetic Chemo-Photodynamic Therapy.
Ma J; Wu H; Li Y; Liu Z; Liu G; Guo Y; Hou Z; Zhao Q; Chen D; Zhu X
Pharm Res; 2018 Feb; 35(3):57. PubMed ID: 29423532
[TBL] [Abstract][Full Text] [Related]
6. Codelivery of Anti-PD-1 Antibody and Paclitaxel with Matrix Metalloproteinase and pH Dual-Sensitive Micelles for Enhanced Tumor Chemoimmunotherapy.
Su Z; Xiao Z; Wang Y; Huang J; An Y; Wang X; Shuai X
Small; 2020 Feb; 16(7):e1906832. PubMed ID: 31990457
[TBL] [Abstract][Full Text] [Related]
7. Oxygen-independent combined photothermal/photodynamic therapy delivered by tumor acidity-responsive polymeric micelles.
Han Y; Chen Z; Zhao H; Zha Z; Ke W; Wang Y; Ge Z
J Control Release; 2018 Aug; 284():15-25. PubMed ID: 29894709
[TBL] [Abstract][Full Text] [Related]
8. A pH-responsive stellate mesoporous silica based nanophotosensitizer for in vivo cancer diagnosis and targeted photodynamic therapy.
Lin AL; Li SZ; Xu CH; Li XS; Zheng BY; Gu JJ; Ke MR; Huang JD
Biomater Sci; 2018 Dec; 7(1):211-219. PubMed ID: 30426113
[TBL] [Abstract][Full Text] [Related]
9. Radiolabeling,
Er O; Tuncel A; Ocakoglu K; Ince M; Kolatan EH; Yilmaz O; Aktaş S; Yurt F
Mol Pharm; 2020 Jul; 17(7):2648-2659. PubMed ID: 32412765
[TBL] [Abstract][Full Text] [Related]
10. PEG-Sheddable Nanodrug Remodels Tumor Microenvironment to Promote Effector T Cell Infiltration and Revise Their Exhaustion for Breast Cancer Immunotherapy.
Huang T; Zhang Q; Yi J; Wang R; Zhang Z; Luo P; Zeng R; Wang Y; Tu M
Small; 2023 Sep; 19(38):e2301749. PubMed ID: 37211704
[TBL] [Abstract][Full Text] [Related]
11. Tumor acidity-activatable macromolecule autophagy inhibitor and immune checkpoint blockade for robust treatment of prostate cancer.
Wang Y; Lei H; Yan B; Zhang S; Xu B; Lin M; Shuai X; Huang J; Pang J
Acta Biomater; 2023 Sep; 168():593-605. PubMed ID: 37474083
[TBL] [Abstract][Full Text] [Related]
12. Nanodrug modified with engineered cell membrane targets CDKs to activate aPD-L1 immunotherapy against liver metastasis of immune-desert colon cancer.
Ding D; Liang R; Li T; Lan T; Li Y; Huang S; He G; Ren J; Li W; Zheng Z; Chen T; Fang J; Huang L; Shuai X; Wei B
J Control Release; 2024 May; 369():309-324. PubMed ID: 38554771
[TBL] [Abstract][Full Text] [Related]
13. Immune/Hypoxic Tumor Microenvironment Regulation-Enhanced Photodynamic Treatment Realized by pH-Responsive Phase Transition-Targeting Nanobubbles.
Zhao M; Yang X; Fu H; Chen C; Zhang Y; Wu Z; Duan Y; Sun Y
ACS Appl Mater Interfaces; 2021 Jul; 13(28):32763-32779. PubMed ID: 34235912
[TBL] [Abstract][Full Text] [Related]
14. Autophagy inhibitor enhance ZnPc/BSA nanoparticle induced photodynamic therapy by suppressing PD-L1 expression in osteosarcoma immunotherapy.
Yu W; Wang Y; Zhu J; Jin L; Liu B; Xia K; Wang J; Gao J; Liang C; Tao H
Biomaterials; 2019 Feb; 192():128-139. PubMed ID: 30448697
[TBL] [Abstract][Full Text] [Related]
15. Cancer targeting with biomolecules: a comparative study of photodynamic therapy efficacy using antibody or lectin conjugated phthalocyanine-PEG gold nanoparticles.
Obaid G; Chambrier I; Cook MJ; Russell DA
Photochem Photobiol Sci; 2015 Apr; 14(4):737-47. PubMed ID: 25604735
[TBL] [Abstract][Full Text] [Related]
16. Sheddable Prodrug Vesicles Combating Adaptive Immune Resistance for Improved Photodynamic Immunotherapy of Cancer.
Gao A; Chen B; Gao J; Zhou F; Saeed M; Hou B; Li Y; Yu H
Nano Lett; 2020 Jan; 20(1):353-362. PubMed ID: 31793787
[TBL] [Abstract][Full Text] [Related]
17. Development and in vitro proof-of-concept of interstitially targeted zinc- phthalocyanine liposomes for photodynamic therapy.
Broekgaarden M; de Kroon AI; Gulik TM; Heger M
Curr Med Chem; 2014; 21(3):377-91. PubMed ID: 23931271
[TBL] [Abstract][Full Text] [Related]
18. Engineered macrophages as near-infrared light activated drug vectors for chemo-photodynamic therapy of primary and bone metastatic breast cancer.
Huang Y; Guan Z; Dai X; Shen Y; Wei Q; Ren L; Jiang J; Xiao Z; Jiang Y; Liu D; Huang Z; Xu X; Luo Y; Zhao C
Nat Commun; 2021 Jul; 12(1):4310. PubMed ID: 34262026
[TBL] [Abstract][Full Text] [Related]
19. Hybrid Liquid Crystal Nanocarriers for Enhanced Zinc Phthalocyanine-Mediated Photodynamic Therapy.
Nag OK; Naciri J; Erickson JS; Oh E; Delehanty JB
Bioconjug Chem; 2018 Aug; 29(8):2701-2714. PubMed ID: 29990422
[TBL] [Abstract][Full Text] [Related]
20. Near-Infrared Activatable Phthalocyanine-Poly-L-Glutamic Acid Conjugate: Enhanced in Vivo Safety and Antitumor Efficacy toward an Effective Photodynamic Cancer Therapy.
Cheah HY; Gallon E; Dumoulin F; Hoe SZ; Japundžić-Žigon N; Glumac S; Lee HB; Anand P; Chung LY; Vicent MJ; Kiew LV
Mol Pharm; 2018 Jul; 15(7):2594-2605. PubMed ID: 29763568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
